Sale

Gene Synthesis Market

Global Gene Synthesis Market Size, Forecast: By Components: Synthesizer, Consumables, Software and Services; By Gene Therapy: Standard Gene, Express Gene, Complex Gene, Others; By Application: Synthetic Biology, Genetic Engineering, Vaccine Design, Others; By Gene Synthesis Type; Regional Analysis; Supplier Landscape; 2024-2032

Global Gene Synthesis Market Outlook

The global gene synthesis market size was valued at USD 2.42 billion in 2023, driven by the increasing prevalence of genetic disorders across the globe. The market is anticipated to grow at a CAGR of 21.2% during the forecast period of 2024-2032 to achieve a value of USD 13.66 billion by 2032.

 

Gene Synthesis: Introduction

Gene synthesis is a method which is used to generate or produce artificial genes in the laboratory. It enables the scientists to design and build custom DNA sequences that can later be used to manipulate the behaviours and characteristics of organisms or humans. Scientists insert these altered DNA into the body of the target and then observe the outcomes of the underlying experiments or trials. The complete process of gene synthesis consists of five steps including design, synthesis, assembly, verification, and expression. At first, the designing of sequence is being done by keeping the expected functionality of the living cell in mind. Then the gene synthesis takes place which is processed chemically. The basic building blocks of DNA (adenine, thymine, guanine, and cytosine) are linked together in the order specified by the design. The small, synthesized fragments are then assembled into full-length genes. This can be done with the use of a variety of methods such as polymerase chain reaction (PCR). Then happens the verification.

 

It is basically matching the intended design with the outcome of assembled gene. The synthesized gene at this stage is ready to be inserted into a living cell (like a bacteria or yeast cell) to "express" the gene, which means that the cell will read the DNA sequence and produce the protein that the gene has been coded for.

 

Global Gene Synthesis Market Analysis

Gene synthesis can be used in various fields including vaccine development, drug discovery, agricultural biotechnology, and many other areas of biotechnology and life sciences. The increasing demand of gene synthesis in the fields such as pharmaceuticals and biotechnology industries has been driving the global gene synthesis market growth. The gene synthesis is widely applicable in the development of drugs. Pharmaceutical companies along with biotech companies are suing gene synthesis to develop new therapies such as personalized medicines and vaccines.

 

Additionally, the increasing technological advancements in the field of synthetic biology are making gene synthesis to be more efficient and cost-effective. This includes updating gene design software, DNA synthesis and assembly technologies, and techniques for integrating synthetic genes into host organisms. The market is witnessing increased funding and investment from both public and private sources. This is leading to increased rate of research and development activities and more innovation. The global gene synthesis market development is driven by the increased focus on using gene synthesis for agricultural applications, such as the development of genetically modified crops with improved traits.

 

Global Gene Synthesis Market Segmentations

Market Breakup by Components

  • Synthesizer
  • Consumables
  • Software and Services

 

Market Breakup by Gene Therapy

  • Standard Gene 
  • Express Gene 
  • Complex Gene 
  • Others

 

Market Breakup by Application

  • Synthetic Biology 
  • Genetic Engineering 
  • Vaccine Design 
  • Therapeutics Antibodies 
  • Others

 

Market Breakup by Gene Synthesis Type

  • Gene Library Synthesis 
  • Solid Phase Synthesis 
  • Chip-Based DNA Synthesis 
  • PCR-Based Enzyme Synthesis

 

Market Breakup by Region

  • North America  
  • Europe 
  • Asia Pacific 
  • Latin America 
  • Middle East and Africa

 

Global Gene Synthesis Market Overview

The increasing research and development in the fields of synthetic biology and genomics is driving demand for gene synthesis services. This is especially prevalent in sectors pharmaceuticals sector along with biotechnology, and academia. The increasing technological advancements in the field have made gene synthesis more efficient, accurate, and affordable which is helping in the market growth. Developments in next-generation sequencing, bioinformatics, and gene editing technologies (like CRISPR) are also directly contributing to market growth. The gene synthesis has been increasingly used in the discovery and development of novel drugs and therapeutics, including personalized medicines and vaccines.

 

Additionally, the increasing prevalence of genetic disorders worldwide is also driving the demand for effective genetic therapies boosting the market. There has been a rise in funding and investments from government and private sectors for research activities that are fuelling the global gene synthesis market expansion.

 

Global Gene Synthesis Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

 

  • ATDBio Ltd 
  • General Biosystems 
  • Macrogen CO. 
  • Boster Biological Technology 
  • Creative Biogene 
  • Bioneer Pacific, 
  • Exonbio 
  • trenzyme GmbH 
  • Twist Bioscience  
  • BioCat GmbH 
  • OriGene Technologies, Inc. 
  • Integrated DNA Technologies 
  • Eurofins Scientific 
  • NZYTech 
  • Genes and Enzymes

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Components
  • Gene Therapy
  • Application
  • Gene Synthesis Type
  • Region
Breakup by Components
  • Synthesizer
  • Consumables
  • Software and Services
Breakup by Gene Therapy
  • Standard Gene
  • Express Gene
  • Complex Gene
  • Others
Breakup by Application
  • Synthetic Biology
  • Genetic Engineering
  • Vaccine Design
  • Therapeutics Antibodies
  • Others
Breakup by Gene Synthesis Type
  • Gene Library Synthesis
  • Solid Phase Synthesis
  • Chip-Based DNA Synthesis
  • PCR-Based Enzyme Synthesis
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • ATDBio Ltd 
  • General Biosystems 
  • Macrogen CO. 
  • Boster Biological Technology 
  • Creative Biogene 
  • Bioneer Pacific, 
  • Exonbio 
  • trenzyme GmbH 
  • Twist Bioscience  
  • BioCat GmbH 
  • OriGene Technologies, Inc. 
  • Integrated DNA Technologies 
  • Eurofins Scientific 
  • NZYTech 
  • Genes and Enzymes

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Global Gene Synthesis Market Overview 

    3.1    Global Gene Synthesis Market Historical Value (2017-2023) 
    3.2    Global Gene Synthesis Market Forecast Value (2024-2032)
4    Global Gene Synthesis Market Landscape
    4.1    Gene Synthesis: Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Gene Synthesis: Product Landscape
        4.2.1    Analysis by Type
        4.2.2    Analysis by Technology
        4.2.3    Analysis by Applications
5    Global Gene Synthesis Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model
    5.4    Key Demand Indicators 
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends  
    5.7    Value Chain Analysis
6    Global Gene Synthesis Market Segmentation
    6.1    Global Gene Synthesis Market by Components
        6.1.1    Market Overview    
        6.1.2    Synthesizer
        6.1.3    Consumables
        6.1.4    Software and Services
    6.2    Global Gene Synthesis Market by Gene Therapy
        6.2.1    Market Overview
        6.2.2    Standard Gene
        6.2.3    Express Gene
        6.2.4    Complex Gene
        6.2.5    Others
    6.3    Global Gene Synthesis Market by Application
        6.3.1    Market Overview
        6.3.2    Synthetic Biology
        6.3.3    Genetic Engineering
        6.3.4    Vaccine Design
        6.3.5    Therapeutics Antibodies
        6.3.6    Others
    6.4    Global Gene Synthesis Market by Gene Synthesis Type
        6.4.1    Market Overview
        6.4.2    Gene Library Synthesis
        6.4.3    Solid Phase Synthesis
        6.4.4    Chip-Based DNA Synthesis
        6.4.5    PCR-Based Enzyme Synthesis
    6.5    Global Gene Synthesis Market by Region
        6.5.1    Market Overview
        6.5.2    North America
        6.5.3    Europe 
        6.5.4    Asia Pacific
        6.5.5    Latin America
        6.5.6    Middle East and Africa
7    North America Gene Synthesis Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Gene Synthesis Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Gene Synthesis Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Gene Synthesis Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Gene Synthesis Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Regulatory Framework
    12.1    Regulatory Overview
        12.1.1    US FDA
        12.1.2    EU EMA
        12.1.3    INDIA CDSCO
        12.1.4    JAPAN PMDA
        12.1.5    Others
13    Patent Analysis
    13.1    Analysis by Type of Patent
    13.2    Analysis by Publication year
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Patent Age
    13.5    Analysis by CPC Analysis
    13.6    Analysis by Patent Valuation 
    13.7    Analysis by Key Players
14    Grants Analysis
    14.1    Analysis by year
    14.2    Analysis by Amount Awarded
    14.3    Analysis by Issuing Authority
    14.4    Analysis by Grant Application
    14.5    Analysis by Funding Institute
    14.6    Analysis by NIH Departments
    14.7    Analysis by Recipient Organization 
15    Clinical Trials Analysis
    15.1     Analysis by Trial Registration Year
    15.2    Analysis by Trial Status
    15.3    Analysis by Trial Phase
    15.4    Analysis by Therapeutic Area
    15.5    Analysis by Geography
16    Funding and Investment Analysis
    16.1    Analysis by Funding Instances
    16.2    Analysis by Type of Funding
    16.3    Analysis by Funding Amount
    16.4    Analysis by Leading Players
    16.5    Analysis by Leading Investors
    16.6    Analysis by Geography
17    Partnership and Collaborations Analysis
    17.1    Analysis by Partnership Instances
    17.2    Analysis by Type of Partnership
    17.3    Analysis by Leading Players
    17.4    Analysis by Geography
18    Supplier Landscape
    18.1    ATDBio Ltd
        18.1.1    Financial Analysis
        18.1.2    Product Portfolio
        18.1.3    Demographic Reach and Achievements
        18.1.4    Mergers and Acquisitions
        18.1.5    Certifications
    18.2    General Biosystems
        18.2.1    Financial Analysis
        18.2.2    Product Portfolio
        18.2.3    Demographic Reach and Achievements
        18.2.4    Mergers and Acquisitions
        18.2.5    Certifications
    18.3    Macrogen CO.
        18.3.1    Financial Analysis
        18.3.2    Product Portfolio
        18.3.3    Demographic Reach and Achievements
        18.3.4    Mergers and Acquisitions
        18.3.5    Certifications
    18.4    Boster Biological Technology
        18.4.1    Financial Analysis
        18.4.2    Product Portfolio
        18.4.3    Demographic Reach and Achievements
        18.4.4    Mergers and Acquisitions
        18.4.5    Certifications
    18.5    Creative Biogene
        18.5.1    Financial Analysis
        18.5.2    Product Portfolio
        18.5.3    Demographic Reach and Achievements
        18.5.4    Mergers and Acquisitions
        18.5.5    Certifications
    18.6    Bioneer Pacific,
        18.6.1    Financial Analysis
        18.6.2    Product Portfolio
        18.6.3    Demographic Reach and Achievements
        18.6.4    Mergers and Acquisitions
        18.6.5    Certifications
    18.7    Exonbio
        18.7.1    Financial Analysis
        18.7.2    Product Portfolio
        18.7.3    Demographic Reach and Achievements
        18.7.4    Mergers and Acquisitions
        18.7.5    Certifications
    18.8    trenzyme GmbH
        18.8.1    Financial Analysis
        18.8.2    Product Portfolio
        18.8.3    Demographic Reach and Achievements
        18.8.4    Mergers and Acquisitions
        18.8.5    Certifications
    18.9    Twist Bioscience 
        18.9.1    Financial Analysis
        18.9.2    Product Portfolio
        18.9.3    Demographic Reach and Achievements
        18.9.4    Mergers and Acquisitions
        18.9.5    Certifications
    18.10    BioCat GmbH
        18.10.1    Financial Analysis
        18.10.2    Product Portfolio
        18.10.3    Demographic Reach and Achievements
        18.10.4    Mergers and Acquisitions
        18.10.5    Certifications
    18.11    OriGene Technologies, Inc.
        18.11.1    Financial Analysis
        18.11.2    Product Portfolio
        18.11.3    Demographic Reach and Achievements
        18.11.4    Mergers and Acquisitions
        18.11.5    Certifications
    18.12    Integrated DNA Technologies
        18.12.1    Financial Analysis
        18.12.2    Product Portfolio
        18.12.3    Demographic Reach and Achievements
        18.12.4    Mergers and Acquisitions
        18.12.5    Certifications
    18.13    Eurofins Scientific
        18.13.1    Financial Analysis
        18.13.2    Product Portfolio
        18.13.3    Demographic Reach and Achievements
        18.13.4    Mergers and Acquisitions
        18.13.5    Certifications
    18.14    NZYTech
        18.14.1    Financial Analysis
        18.14.2    Product Portfolio
        18.14.3    Demographic Reach and Achievements
        18.14.4    Mergers and Acquisitions
        18.14.5    Certifications
    18.15    Genes and Enzymes
        18.15.1    Financial Analysis
        18.15.2    Product Portfolio
        18.15.3    Demographic Reach and Achievements
        18.15.4    Mergers and Acquisitions
        18.15.5    Certifications
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket
    
    
*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The market attained a value of about USD 2.42 billion in 2023, driven by the rising prevalence of genetic disorders.

The global market size is anticipated to grow at a CAGR of 21.2% during the forecast period of 2024-2032 and reach a market value of USD 13.66 billion by 2032.

The rising investments from government and private sectors in the research and development activities is among several major factors that are aiding the market growth.

The increased focus on using gene synthesis for agricultural applications, such as the development of genetically modified crops globally is a major trend supporting the market growth.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.

The components can be categorised into synthesizer, consumables, software and services.

The segments can be categorized into standard gene, express gene, and complex gene, among others.

Gene synthesis find wide applications in synthetic biology, genetic engineering, vaccine design, and therapeutics antibodies, among others.

The gene synthesis type can be categorized into gene library synthesis, solid phase synthesis, chip-based DNA synthesis, and PCR-based enzyme synthesis.

Key players involved in the market are ATDBio Ltd, General Biosystems, Macrogen CO., Boster Biological Technology, Creative Biogene, Bioneer Pacific, Exonbio, trenzyme GmbH, Twist Bioscience, BioCat GmbH, OriGene Technologies, Inc., Integrated DNA Technologies, Eurofins Scientific, NZYTech, and Genes and Enzymes.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER